U.S. Silica To Lay Off About 10% Of Total Workforce

By RTTNews Staff Writer ✉ | Published: 11/22/2019 9:30 AM ET

U.S. Silica Holdings Inc. (SLCA) said that it would lay off about 230 employees or 10% of the total company workforce.

It expects annual SG&A savings from the actions as well as other cost reductions to be about $20 million.

The company said it will idle both the Utica, Illinois and Tyler, Texas mines. Other facilities impacted, but not idled are; Crane County in Texas, Sparta, Wisconsin, and Festus, Missouri. The workforce reduction in operations will reduce staffed O&G capacity by 7 million tons, which will be better aligned with current demand.

The company expects to incur about $1.7 million in related severance costs in the fourth quarter of 2019 and will consider any impairment charges as it closes the fourth quarter and fiscal year end.

For comments and feedback contact: editorial@rttnews.com

Business News

Biotech Stocks PDUFA COVID 19 Vaccines peanut allergy Trelegy Ellipta Pain drug exertional heatstroke allergic conjunctivitis

Biotech Stocks Facing FDA Decision In August 2020

New Drugs Approved In June

Coronavirus Vaccines In Human Trials COVID19 Antibodies Spike Protein US Operation Warp Speed

Tracking Coronavirus Vaccines In Human Trials

Editors Pick

Facebook Releases Instagram Reels

Facebook has unveiled Instagram Reels as its answer to the popular Chinese-owned video app TikTok. The social media giant said in a blog post that Instagram Reels is a new way to create short, entertaining videos on Facebook's photo-sharing app Instagram. Facebook reportedly shut down its TikTok clone Lasso in July, ahead of the launch of Instagram Reels.

WD-40 Company Recalls About 130k Units Of X-14 Mildew Stain Remover

WD-40 Company recalled about 130,000 units of X-14 Mildew Stain Remover for potential risk of skin irritation, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. The company said pressure can build up inside the bottle and cause it to fall over and leak, posing a risk of skin irritation.

Bristol-Myers Slips To Loss In Q2, But Results Top Estimates

Biopharmaceutical company Bristol-Myers Squibb Co. on Thursday reported a loss for the second quarter, compared to a profit last year, hurt primarily by hefty amortization expenses. However, adjusted earnings per share and quarterly revenues topped analysts' expectations. Looking ahead, the company raised its adjusted earnings and revenue outlook for the full-year 2020.